PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Cardiology (S.T., T.Y., T.W., T.M., Y.F., M.K., A.K., T.K., M.S., M.A., J.N., K.Y., K.K., M.K., K.T., M.F), Osaka General Medical Center, Osaka, Japan.\', \'Department of Diabetes and Endocrinology (K.F., M.H., Y.F., Y.U.), Osaka General Medical Center, Osaka, Japan.\', \'Department of Medical Statistics, Osaka City University Graduate School of Medicine, Osaka, Japan (S.T., S.S., A.S.).\', \'Center for Clinical Research and Innovation, Osaka City University Hospital, Osaka, Japan (S.S.).\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1161/CIRCHEARTFAILURE.120.007048
?:doi
?:hasPublicationType
?:journal
  • Circulation. Heart failure
is ?:pmid of
?:pmid
?:pmid
  • 33663235
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 4.2
?:rankingScore_hIndex
  • 79
is ?:relation_isRelatedTo_publication of
?:title
  • Effect of Empagliflozin as an Add-On Therapy on Decongestion and Renal Function in Patients With Diabetes Hospitalized for Acute Decompensated Heart Failure: A Prospective Randomized Controlled Study.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all